Average Co-Inventor Count = 2.02
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (16 from 1,974 patents)
2. Teligene Ltd. (6 from 6 patents)
3. Jiangsu Medolution Ltd (3 from 3 patents)
4. Other (2 from 832,843 patents)
5. Hangzhouderenyucheng Biotechnology Ltd (1 from 1 patent)
6. Medolution Limited (1 from 1 patent)
7. Teligene US LLC (1 from 1 patent)
30 patents:
1. 12338251 - Substituted macrocycles useful as kinase inhibitors
2. 12017996 - Substituted quinolines and formulations thereof
3. 11427559 - Substituted quinolines useful as kinase inhibitors
4. 11344553 - Substituted pyrazolopyrimidines useful as kinases inhibitors
5. 11034656 - Maleate salts of (E)-N-(3-cyano-7-ethoxy-4-((4-phenoxyphenyl)amino) quinolin-6-yl)-4-(dimethylamino)but-2-enamide and crystalline forms thereof
6. 10173995 - Pyridine compounds used as PI3 kinase inhibitors
7. 10167264 - Substituted pyrimidines useful as EGFR-T790M kinase inhibitors
8. 10159663 - Substituted macrocycles useful as kinases inhibitors and methods of use thereof
9. 9873701 - Heterocyclic compounds and their uses
10. 9694011 - Substituted pyrazolopyrimidines as kinases inhibitors
11. 9550738 - Bicyclic compounds as kinases inhibitors
12. 9388160 - Quinazoline derivatives as kinases inhibitors and methods of use thereof
13. 9388170 - Substituted aminoquinazolines useful as kinases inhibitors
14. 9353062 - Substituted quinolines as bruton's tyrosine kinases inhibitors
15. 8901135 - Heterocyclic compounds and their uses